Cargando…

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers

BACKGROUND: Despite the accumulation of research papers on aspirin and cancer, there is doubt as to whether or not aspirin is an acceptable and effective adjunct treatment of cancer. The results of several randomised trials are awaited, and these should give clear evidence on three common cancers: c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elwood, Peter C, Morgan, Gareth, Delon, Christine, Protty, Majd, Galante, Julieta, Pickering, Janet, Watkins, John, Weightman, Alison, Morris, Delyth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426031/ https://www.ncbi.nlm.nih.gov/pubmed/34567243 http://dx.doi.org/10.3332/ecancer.2021.1258

Ejemplares similares

Aspirin and cancer: biological mechanisms and clinical outcomes
por: Elwood, Peter, et al.
Publicado: (2022)

Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
por: Elwood, Peter C., et al.
Publicado: (2016)

Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?
por: Elwood, Peter C., et al.
Publicado: (2018)

Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk
por: Elwood, Peter C., et al.
Publicado: (2016)

Prophylactic Aspirin and Public
por: Morgan, Gareth
Publicado: (2013)

Platelets, Aspirin and Cardiovascular Disease
por: Elwood, P. C.
Publicado: (1976)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Aspirin as adjuvant therapy in childhood cancer?
por: Morgan, G
Publicado: (2012)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
por: Langley, R E, et al.
Publicado: (2011)

Aspirin and colorectal cancer.
por: La Vecchia, C., et al.
Publicado: (1997)

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis
por: Smith, Tom, et al.
Publicado: (2014)

Potential contribution of aspirin to cancer control programmes
por: Morgan, G
Publicado: (2008)

The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer
por: Kilari, Rajagopal S., et al.
Publicado: (2019)

Aspirin and lung cancer in women
por: Akhmedkhanov, A, et al.
Publicado: (2002)

Aspirin and endometrial cancer risk
por: Brasky, Theodore M., et al.
Publicado: (2016)

Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses
por: Li, Diangeng, et al.
Publicado: (2018)

Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer
por: Zhu, Yingdong, et al.
Publicado: (2017)

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?
por: Altman, Raul, et al.
Publicado: (2004)

Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK
por: Smith, Tom, et al.
Publicado: (2015)

Does Utilitarian Policy such as Smoking Cessation Lend Support to Wider Aspirin Use?
por: Morgan, Gareth
Publicado: (2015)

Aspirin use and lung cancer in men
por: Holick, C N, et al.
Publicado: (2003)

Molecular targets of aspirin and cancer prevention
por: Alfonso, L, et al.
Publicado: (2014)

Aspirin Resistance
por: Mansour, Khaled, et al.
Publicado: (2009)

Is Aspirin Dangerous
Publicado: (1918)

Preeclampsia and aspirin
por: Ahn, Tae Gyu, et al.
Publicado: (2023)

Low dose aspirin and pregnancy: how important is aspirin resistance?
por: Navaratnam, K, et al.
Publicado: (2016)

Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2023)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

Alleviating Aspirin-Induced Gastric Injury by Binding Aspirin to β-Lactoglobulin
por: Chen, Jin, et al.
Publicado: (2022)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Aspirin use and cancers of the upper aerodigestive tract
por: Bosetti, C, et al.
Publicado: (2003)

Aspirin therapy for cancer: it is never too late
por: Jankowski, J A Z, et al.
Publicado: (2011)

Regular use of aspirin and pancreatic cancer risk
por: Menezes, Ravi J, et al.
Publicado: (2002)

Regular aspirin use and lung cancer risk
por: Moysich, Kirsten B, et al.
Publicado: (2002)

Clinical evidence for the use of aspirin in the treatment of cancer
por: Langley, Ruth E
Publicado: (2013)

Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?
por: Coyle, Christopher, et al.
Publicado: (2016)

Aspirin and Statin Use and the Risk of Gallbladder Cancer
por: Prasai, Kritika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2dv5kmakuodkgccljc87kttqjh